HKUST may reserve 20% of first medical school intake for non-locals
In 2028-29, the Hong Kong University of Science and Technology (HKUST) plans to launch a new graduate medical school, potentially reserving 20% of its 50 initial places for non-local students, primarily from mainland China. Applicants to the four-year program will need to pass an international admission test, with preference given to those with biotechnology backgrounds.

Briefing Summary
AI-generatedIn 2028-29, the Hong Kong University of Science and Technology (HKUST) plans to launch a new graduate medical school, potentially reserving 20% of its 50 initial places for non-local students, primarily from mainland China. Applicants to the four-year program will need to pass an international admission test, with preference given to those with biotechnology backgrounds. Tuition for local students with bachelor's degrees will align with undergraduate rates, while non-local students will face higher fees. HKUST aims to invest over HK$7 billion over 25 years to establish the school, which will integrate artificial intelligence, biotechnology, and clinical medicine to train a new generation of tech-savvy doctors, complementing the city's two existing medical schools.
Article analysis
Model · rule-basedKey claims
5 extractedThis innovative medical school combines artificial intelligence, biotechnology and clinical medicine.
HKUST will invest more than HK$7 billion in the medical school over 25 years.
Applicants must pass an international admission test and the university prefers those with a background in biotechnology.
The HKUST medical school's inaugural intake will be in 2028-29 and consist of 50 places.
HKUST may reserve 20% of first medical school intake for non-local students.